PL2656846T3 - Fosfomycynowa kompozycja farmaceutyczna - Google Patents

Fosfomycynowa kompozycja farmaceutyczna

Info

Publication number
PL2656846T3
PL2656846T3 PL11851679.8T PL11851679T PL2656846T3 PL 2656846 T3 PL2656846 T3 PL 2656846T3 PL 11851679 T PL11851679 T PL 11851679T PL 2656846 T3 PL2656846 T3 PL 2656846T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
phosphomycin
phosphomycin pharmaceutical
composition
pharmaceutical
Prior art date
Application number
PL11851679.8T
Other languages
English (en)
Inventor
Darder Carlos Picornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2656846T3 publication Critical patent/PL2656846T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11851679.8T 2010-12-24 2011-12-19 Fosfomycynowa kompozycja farmaceutyczna PL2656846T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201001613A ES2385158B1 (es) 2010-12-24 2010-12-24 Composición farmacéutica de fosfomicina

Publications (1)

Publication Number Publication Date
PL2656846T3 true PL2656846T3 (pl) 2016-09-30

Family

ID=46313210

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11851679.8T PL2656846T3 (pl) 2010-12-24 2011-12-19 Fosfomycynowa kompozycja farmaceutyczna

Country Status (14)

Country Link
EP (1) EP2656846B1 (pl)
JP (1) JP6012622B2 (pl)
KR (1) KR20140091649A (pl)
CN (1) CN103282038B (pl)
BR (1) BR112013016029A2 (pl)
CA (1) CA2821382C (pl)
DK (1) DK2656846T3 (pl)
EA (1) EA023846B1 (pl)
ES (2) ES2385158B1 (pl)
HU (1) HUE027572T2 (pl)
MX (1) MX342938B (pl)
PL (1) PL2656846T3 (pl)
PT (1) PT2656846T (pl)
WO (1) WO2012085304A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017111718A1 (en) 2015-12-25 2017-06-29 Yusuf Toktamiş Öğün The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
CA3147662A1 (en) 2021-02-10 2022-08-10 Labiana Health, S.L. New fosfomycin tablet formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1231013B (it) 1989-07-27 1991-11-08 Zambon Spa Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'.
ES2103682B1 (es) * 1995-09-20 1998-04-01 Lilly Sa Composicion farmaceutica oral de fluoxetina, solida y con caracteristicas organolepticas mejoradas.
ITMI20021725A1 (it) * 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.
ES2244333B1 (es) * 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.

Also Published As

Publication number Publication date
KR20140091649A (ko) 2014-07-22
JP6012622B2 (ja) 2016-10-25
HK1188959A1 (zh) 2014-05-23
EP2656846A1 (en) 2013-10-30
MX342938B (es) 2016-10-19
EP2656846B1 (en) 2016-03-30
CA2821382A1 (en) 2012-06-28
ES2574916T3 (es) 2016-06-23
CN103282038A (zh) 2013-09-04
EP2656846A4 (en) 2014-07-09
HUE027572T2 (en) 2016-10-28
CA2821382C (en) 2019-01-08
ES2385158B1 (es) 2013-05-28
PT2656846T (pt) 2016-07-08
CN103282038B (zh) 2016-08-10
BR112013016029A2 (pt) 2017-06-13
WO2012085304A1 (es) 2012-06-28
JP2014500301A (ja) 2014-01-09
MX2013007232A (es) 2013-08-15
DK2656846T3 (en) 2016-07-04
EA023846B1 (ru) 2016-07-29
ES2385158A1 (es) 2012-07-19
EA201390760A1 (ru) 2013-12-30

Similar Documents

Publication Publication Date Title
IL245326A0 (en) pharmaceutical preparation
PL2619182T3 (pl) Kompozycja farmaceutyczna
IL225457A0 (en) Pharmaceutical composition
HUE031336T2 (hu) Gyógyszerészeti készítmények
ZA201304189B (en) Novel pharmaceutical composition
PT2579858E (pt) Composição farmacêutica que contém ivabradina
ZA201301920B (en) Pharmaceutical composition
GB201010453D0 (en) Pharmaceutical composition
SG10201508982TA (en) Pharmaceutical compositions
PL2651396T3 (pl) Kompozycje farmaceutyczne zawierające alisporiwir
IL221501A (en) Medicinal product containing miramistine
EP2560678A4 (en) PHARMACEUTICAL COMPOSITIONS
GB201001911D0 (en) Pharmaceutical composition
GB201019775D0 (en) Pharmaceutical composition
HU1000006D0 (en) Improved pharmaceutical composition
GB201008590D0 (en) Pharmaceutical compositions
SG10201509530YA (en) Pharmaceutical compositions